Intra-Cellular: Q3 Earnings Snapshot
In this article:
NEW YORK (AP) — NEW YORK (AP) — Intra-Cellular Therapies Inc. (ITCI) on Thursday reported a loss of $24.3 million in its third quarter.
On a per-share basis, the New York-based company said it had a loss of 25 cents.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.
The biopharmaceutical company posted revenue of $126.2 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $118.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ITCI at https://www.zacks.com/ap/ITCI
